Especially longitudinal studies investigating the association between plasma amyloid and tau levels and the development of clinical dementia need to be conducted, and the relationships between plasma Aβ and tau levels and AD pathology in DS individuals' brains should additionally be explored using neuroimaging studies. The gene discussed is MAPT; the disease is Alzheimer disease.